摘要
本文综述了基质金属蛋白酶分子的特征,及各基质金属蛋白酶分子在糖尿病视网膜病变发生发展进程中作用的研究进展。
出处
《中外医疗》
2009年第25期156-157,共2页
China & Foreign Medical Treatment
参考文献30
-
1Visser, Nagase H. Matrix metalloproteinases and tissue inhibitor of metalloproteinases. Structure,function and biochemistry[J]. Circ Res,2003,92(8) :827.
-
2Sternlicht MD, Werb G. How matrix metalloproteinases regulate cell behavior[J]. Annu Rev Cell Develop Biol, 2001,17:463.
-
3Limb GA, Matter K, Murphy G, et al. Matrix metalloproteinase- 1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis[J]. Am J Pathol,2005,166 (5):1555.
-
4Kwan JA, Schulze C J, Wang W, et al. Matrix metalloproteinase-2 (MMP -2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP ribose) polymerase (PARP) in vitro[J]. FASEB J,2004,18 (6) :690.
-
5Luo D, Mari B, Stoll I, et al. Alternative splicing and promoter usage gen.erates an intracellular stromelysin 3 isoform directly translated as an active matrix metalloproteinase[J]. J Biol Chem 2002,277(28) :25527.
-
6Fong DS, Aiello LP, Ferris FL, et al. Diabetic retinopathy[J]. Diabetes Care,2004,27(10):2540- 2553.
-
7Kohno T, Sorgente N, Ishibashi T, et al. Immunofluorescent studies of fibronectin and laminin in the human eye[J]. Invest Ophthalmol Vis Sci,1987,28(3):506-514.
-
8Russell SR, Shepherd JD, Hageman GS. Distribution of glycoconjugates in the human retinal internal limiting membrane[J].Invest Ophthalmol Vis Sci, 1991,32(7):1986- 1995.
-
9Ishizaki M, Westerhausen-Larson A, Kino J, et al.Distribution of collagen IV in human ocular tissues[J].Invest Ophthalmol Vis Sci, 1993,34(9):2680- 2689.
-
10Gilbert C,Hiscott P, Unger W, et al. Inflammation and the formation of epiretinal membranes[J].Eye,1988,2(S1):40-56.
同被引文献21
-
1曹丹,柳林.TGF-β/Smads信号转导通路与糖尿病视网膜病变[J].国际眼科杂志,2005,5(3):532-536. 被引量:3
-
2赵宏,张效房.增生性糖尿病视网膜病变玻璃体切除物中MMP-2和MMP-9的表达[J].郑州大学学报(医学版),2007,42(3):556-557. 被引量:6
-
3JohnstoneMT,V?vesA.糖尿病与心血管疾病[M].孙丰雷,译.济南:山东科学技术出版社,2008:261.
-
4Mo N, Li ZQ, Li J, et al. Curcumin inhibits TGF - 131 - induced MMP- 9 and invasion through ERK and Smad signaling in breast cancer MDAMB-231 cells [J]. Asian Pac J Cancer Prey, 20i2, 13 (11): 5709-5714.
-
5Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions [J]. Circ Res, 2005, 97 (6): 512-523.
-
6刘绍燕.密蒙花方防治糖尿病视网膜病变TGF-β/Smad信号转导机制研究[D].北京:中国中医科学院,20(0.
-
7Spirin KS, Saghizadeh M, Lewin SL, et al. Basement membrane and growthfactor gene expression in normal and diabetic human retinas [J]. Curt Eye Res, 1999, 18 (6) : 490-499.
-
8Papetti M, Shujath J, Riley KN, et al. FGF- 2 antagonizes the TGF - betal - mediated induction of pericyte alpha - smooth muscle actin expression: a role formyf - 5 and Smad - mediated sigaaling pathways [ J ]. Invest Ophthalmol Vis Sei, 2003, 44 ( 11 ) : 4994 - 5005.
-
9Ochiai Y, Ochiai H. Higher concentration of transforminggrowthfactor " beta in aqueous humor of glaueomatouseyes and diabetic eyes [ J ]. Jpn J Ophthalmol, 2002, 46 (3): 249-253.
-
10Miyata Y, Iwata T, Ohba K, etal. Expression "of matrixmetalloproteinase- 7 on cancer cells and tissue endothelial cells in renal careinoma: prognostic implications and clinical significance for invasion and metastasis [ J ]. Clin Cancer Res, 2006, 12 : 6998 - 7003.
引证文献2
-
1何洁,郝改梅,武志黔,韩静,吴晏,薛晓兴,李玉波,王伟.活血解毒方对糖尿病大鼠视网膜病变的影响研究[J].中国全科医学,2015,18(5):507-512. 被引量:5
-
2李琼锋.自拟降压汤联合钙离子拮抗剂治疗老年高血压的疗效观察[J].中国医疗设备,2017,32(B04):323-323. 被引量:1
二级引证文献6
-
1杜旭勤,石立鹏,李新华,程萍,谭梅.中药干预糖尿病视网膜病变研究近况[J].实用中医药杂志,2016,32(6):620-622. 被引量:2
-
2李玉秀,马力,吴瑞,缪娟,王竹风,石白,安然,陈康.2型糖尿病迟发性腺功能低下的Smad通路机制[J].中国老年学杂志,2016,36(13):3160-3162. 被引量:4
-
3王宏亮,吕甜甜,邢玮,韩静,吴晏,张子剑,王伟.活血解毒方对糖尿病大鼠视网膜组织中microRNA表达的影响[J].环球中医药,2017,10(3):257-261. 被引量:1
-
4栗艳萍,刘声.血脂康胶囊联合缬沙坦对高血压视网膜病变硬化期的短期效果[J].中国医药导报,2018,15(3):107-109. 被引量:5
-
5刘小彬.自拟降压汤联合钙离子拮抗剂治疗老年高血压的临床疗效观察[J].内蒙古中医药,2018,37(4):56-57. 被引量:1
-
6宋旺,袁媛,葛争艳,金龙,许扬.单味中药及复方对实验性糖尿病视网膜病变防治作用的研究进展[J].中国药理学与毒理学杂志,2019,33(3):224-231. 被引量:14
-
1王建仓,孙瑞雪,邸平会,赵宁.糖尿病患者白内障术后眼底荧光血管造影分析[J].河北医药,2009,31(23):3223-3224. 被引量:1
-
2许荣,周莉,王勇.同轴微切口超声乳化术后玻璃体后脱离的临床观察[J].国际眼科杂志,2013,13(9):1845-1847. 被引量:1
-
3张章,周如侠,王林农.角膜内皮移植术新进展[J].医学研究生学报,2015,28(8):889-892. 被引量:6
-
4朱亚楠,姚克.可调节人工晶状体新进展[J].国际眼科纵览,2009,33(5):323-327.
-
5李付亮,阴正勤,孟晓红.玻璃体腔注射曲安奈德治疗脉络膜新生血管膜的疗效观察[J].第三军医大学学报,2004,26(5):460-462.
-
6俞萍萍,孙朝晖.青少年近视与调节灵敏度改变的相关性研究[J].科技通报,2008,24(6):839-841. 被引量:4
-
7孙京华,张煜昭,王慧,王净信,刘常明.VEGF和PEDF在实验性大鼠角膜新生血管组织中的动态表达[J].眼科新进展,2006,26(8):573-576. 被引量:7
-
8洪玉,徐国兴.MMP-1、MMP-3、TIMP-1对外伤性PVR的影响研究[J].国际眼科杂志,2008,8(11):2195-2198. 被引量:3
-
9王静,梁亮.P2X7受体在糖尿病视网膜病变中的作用[J].重庆医学,2016,45(14):1987-1989. 被引量:1
-
10何理烨,梁亮,朱梦男.角膜滞后量在青光眼诊断和治疗中的应用价值[J].中华眼科杂志,2017,53(2):140-143. 被引量:4